Marshall Wace North America’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$35M Buy
+288,732
New +$35.1M 0.15% 152
2021
Q2
Sell
-24,152
Closed -$2.31M 1769
2021
Q1
$2.31M Buy
24,152
+3,812
+19% +$348K 0.01% 783
2020
Q4
$1.61M Sell
20,340
-175,516
-90% -$12.7M 0.01% 812
2020
Q3
$12.1M Buy
+195,856
New +$12.7M 0.08% 255
2020
Q1
Sell
-7,232
Closed -$396K 1592
2019
Q4
$396K Buy
+7,232
New +$379K ﹤0.01% 860
2019
Q3
Sell
-6,656
Closed -$348K 1548
2019
Q2
$348K Buy
+6,656
New +$335K ﹤0.01% 952
2019
Q1
Sell
-7,536
Closed -$272K 1890
2018
Q4
$272K Buy
+7,536
New +$315K ﹤0.01% 899
2018
Q3
Sell
-152,140
Closed -$5.63M 1359
2018
Q2
$5.63M Buy
+152,140
New +$5.81M 0.03% 483
2017
Q4
Sell
-67,628
Closed -$2.05M 1604
2017
Q3
$2.05M Sell
67,628
-385,668
-85% -$11.4M 0.01% 790
2017
Q2
$13.4M Buy
453,296
+397,792
+717% +$10.9M 0.1% 257
2017
Q1
$1.42M Buy
+55,504
New +$1.43M 0.01% 642
2013
Q4
Sell
-11,200
Closed -$224K 829
2013
Q3
$224K Buy
+11,200
New +$213K 0.01% 545

Other funds holding TECH

Marshall Wace North America's TECH Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Bio-Techne (TECH) in Q3 2021: 288,732 shares worth $35M. The stake represents 0.15% of the portfolio and ranks #152 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in TECH as recently as Q1 2021.

Marshall Wace North America first reported a position in TECH in Q3 2013 and has held it in 12 quarters since. 566 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

  • Marshall Wace North America held 288,732 shares of Bio-Techne worth $35M as of Q3 2021.
  • Bio-Techne was a new Marshall Wace North America position in Q3 2021.
  • Bio-Techne made up 0.15% of Marshall Wace North America's portfolio in Q3 2021, its #152 holding.
  • Marshall Wace North America first reported a position in Bio-Techne in Q3 2013 and has held it in 12 quarters since.
  • 566 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.